NHGRI logo

Advancing Genomic Medicine Research (AGMR)

The AGMR program stimulates innovation and advance understanding of when, where and how best to implement the use of genomic information and technologies in clinical care.

Overview

Historically, NHGRI has largely funded genomic medicine research through multi-disciplinary consortia. The AGMR program expands NHGRI’s genomic medicine portfolio to include focused research projects that propose nimble, flexible approaches to problems in application or implementation of genomic medicine. AGMR investigators participate in at least one annual meeting, allowing for independent but synergistic efforts among grantees and promoting rapid sharing of successful approaches and resulting data.

Funding Opportunities

  • RFA-HG-23-032Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
    Application Due Date(s): December 01, 2023, July 08, 2024, February 11, 2025
    Expiration Date: February 12, 2025
     
  • RFA-HG-23-033Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Application Due Date(s): December 01, 2023, July 08, 2024, February 11, 2025
    Expiration Date: February 12, 2025
     
  • RFA-HG-23-048: Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
    Application Due Date(s): December 01, 2023, July 08, 2024, February 11, 2025
    Expiration Date: February 12, 2025
     
  • NOT-HG-24-002: Notice of Special Interest (NOSI): Advancing Genomic Medicine Research through Small Businesses
     
  • RFA-HG-20-036Advancing Genomic Medicine Research (Clinical Trial Optional) (R01)
    Due Dates: August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023
    Expiration Date: March 14, 2023

    NOT-HG-23-034Notice of Intent to Publish a Notice of Funding Opportunity for Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
     
  • RFA-HG-20-037Advancing Genomic Medicine Research (Clinical Trial Optional) (R21)
    Due Dates: August 3, 2020; March 8, 2021; November 2, 2021; August 1, 2022; March 13, 2023
    Expiration Date: March 14, 2023

    NOT-HG-23-035Notice of Intent to Publish a Notice of Funding Opportunity for Advancing Genomic Medicine Research (R21 Clinical Trial Optional)

Program Staff

Chang
Christine Q. Chang, M.P.H.
  • Program Director
  • Division of Genomic Medicine
Renee Rider
Renee Rider, M.S., J.D., LCGC
  • Program Director
  • Division of Genomic Medicine
Jessica Reinach
Jessica Reinach, B.A.
  • Scientific Program Analyst
  • Division of Genomic Medicine
Weini Ogbagiorgis
Weini Ogbagiorgis, B.S.
  • Scientific Program Analyst
  • Division of Genomic Medicine

Last updated: August 1, 2024